Literature DB >> 3123389

Reversible phase variation of expression of Neisseria meningitidis class 5 outer membrane proteins and their relationship to gonococcal proteins II.

T H Kawula1, E L Aho, D S Barritt, D G Klapper, J G Cannon.   

Abstract

Neisseria meningitidis class 5 proteins are major outer membrane proteins that share many properties with the proteins II (P.II) of Neisseria gonorrhoeae. We generated two bactericidal monoclonal antibodies, each of which bound specifically to one of the two identified class 5 proteins produced by N. meningitidis FAM18. The monoclonal antibodies also bound to class 5 proteins of a limited number of other meningococcal strains. Using the bactericidal activity of the monoclonal antibodies, we demonstrated that expression of both class 5 proteins was subject to reversible phase variation in vitro. The N-terminal amino acid sequence of a purified class 5 protein revealed striking similarity to the N-terminal amino acid sequence of gonococcal P.II proteins. Using a cloned class 5 gene, we identified three potential class 5 gene loci in N. meningitidis FAM18. These class 5 sequences also had homology with gonococcal P.II gene sequences and contained the CTCTT repeat sequence believed to be important in the regulation of gonococcal P.II expression.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123389      PMCID: PMC259292          DOI: 10.1128/iai.56.2.380-386.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Biological properties of two distinct pilus types produced by isogenic variants of Neisseria gonorrhoeae P9.

Authors:  P R Lambden; J N Robertson; P J Watt
Journal:  J Bacteriol       Date:  1980-01       Impact factor: 3.490

3.  Effect of dilution rate on lipopolysaccharide and serum resistance of Neisseria gonorrhoeae grown in continuous culture.

Authors:  S A Morse; C S Mintz; S K Sarafian; L Bartenstein; M Bertram; M A Apicella
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

4.  Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies.

Authors:  W J Black; R S Schwalbe; I Nachamkin; J G Cannon
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

5.  Five structural classes of major outer membrane proteins in Neisseria meningitidis.

Authors:  C M Tsai; C E Frasch; L F Mocca
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

6.  Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen.

Authors:  I Nachamkin; J G Cannon; R S Mittler
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

8.  Colony opacity and protein II compositions of gonococci.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Association of virulence of Neisseria meningitidis with transparent colony type and low-molecular-weight outer membrane proteins.

Authors:  D S Stephens; Z A McGee
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

10.  Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae.

Authors:  M S Blake; E C Gotschlich
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

View more
  14 in total

1.  HmbR, a hemoglobin-binding outer membrane protein of Neisseria meningitidis, undergoes phase variation.

Authors:  A R Richardson; I Stojiljkovic
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis.

Authors:  J P Woods; J G Cannon
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 4.  Genetic loci and linkage associations in Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  S E West; V L Clark
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Antigenic and molecular conservation of the gonococcal NspA protein.

Authors:  M Plante; N Cadieux; C R Rioux; J Hamel; B R Brodeur; D Martin
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis.

Authors:  Martin J Callaghan; Keith A Jolley; Martin C J Maiden
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Distribution of a protein antigenically related to the major anaerobically induced gonococcal outer membrane protein among other Neisseria species.

Authors:  G T Hoehn; V L Clark
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

8.  Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.

Authors:  M J Callaghan; S Lewis; M Sadarangani; S E S Bailey; H Chan; D J P Ferguson; J P Derrick; I Feavers; M C Maiden; A J Pollard
Journal:  Infect Immun       Date:  2011-04-04       Impact factor: 3.441

9.  Preliminary evaluation of the ligase chain reaction for specific detection of Neisseria gonorrhoeae.

Authors:  L Birkenmeyer; A S Armstrong
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

10.  Immune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins.

Authors:  M R Lifely; Z Wang
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.